Bridgepoint Group plc
("Bridgepoint" or the "Company")
Additional Listing
Bridgepoint announces that it intends to issue 1,762,501 ordinary shares of £0.00005 each ("New Ordinary Shares") to satisfy vesting awards under Bridgepoint's Long Term Incentive Plan. The New Ordinary Shares will rank pari passu with existing ordinary shares in issue.
An application has been made for the admission of the New Ordinary Shares to listing on the Official List and to trading on the LSE's main market for listed securities.
Admission is expected to occur on 28 March 2025.
In conformity with the Financial Conduct Authority's Disclosure and Transparency Rules, Bridgepoint announces that its total issued share capital following the issue of the New Ordinary Shares will comprise:
| • |
825,563,402 ordinary shares of £0.00005 each with voting rights; and |
| • |
500 deferred shares of £81 each, 1 deferred share of £1, and 1 deferred share of £0.01, each with no voting rights. |
Bridgepoint holds no shares in treasury. Following the issue of the New Ordinary Shares the total number of voting rights in the Company will therefore be 825,563,402, and this figure may be used by shareholders at such time as the denominator for the calculation by which they will determine if they are required to notify their interest in, or a change to their interest in, Bridgepoint under the Disclosure Guidance and Transparency Rules.
ENQUIRIES
Bridgepoint
| Analysts and investors Adam Key Adam.Key@bridgepointgroup.com |
Media Christian Jones Christian.Jones@bridgepointgroup.com +44 20 7034 3500 |
FGS Global (Public Relations Adviser to Bridgepoint)
James Murgatroyd / +44 20 7251 3801 / +44 7768 254 911
Anjali Unnikrishnan / +44 20 7251 3801 / +44 7826 534 233
Issued by Bridgepoint Group plc
LEI: 213800KFNMVI8PDZX472
Registered in England and Wales no. 11443992
Registered office: 5 Marble Arch, London, W1H 7EJ